Inherited defects of thyroid hormone metabolism;Altérations héréditaires du métabolisme des hormones thyroïdiennes

Annales d'Endocrinologie

Volumn 72, Issue 2, 2011, Pages 95-98

  Dumitrescu, A M ^a   Refetoff, S ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Deiodinase; Growth delay; Infertility; Myopathy; SBP2; Selenoprotein; Thyroid hormone

Indexed keywords

BINDING PROTEIN; LIOTHYRONINE; SELENIUM; SELENOCYSTEINE INSERTION SEQUENCE BINDING PROTEIN 2; SELENOMETHIONINE; SELENOPROTEIN; THYROID HORMONE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG EFFICACY; GENE; GENE MUTATION; GROWTH RETARDATION; HUMAN; INBORN ERROR OF METABOLISM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SBP2 GENE; SELENOCYSTEINE INSERTION SEQUENCE BINDING PROTEIN 2 DEFICIENCY; SUPPLEMENTATION; THYROID HORMONE METABOLISM;

DIETARY SUPPLEMENTS; HUMANS; IODIDE PEROXIDASE; MALE; MUTATION; RNA-BINDING PROTEINS; SELENIUM; SELENOPROTEINS; THYROID GLAND; THYROID HORMONES;

EID: 79955740072     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2011.03.011     Document Type: Article

References (23)

1. Driscoll D.M., Copeland P.R. Mechanism and regulation of selenoprotein synthesis. Annu Rev Nutr 2003, 23:17-40.
2. Chavatte L., Brown B.A., Driscoll D.M. Ribosomal protein L30 is a component of the UGA-selenocysteine recoding machinery in eukaryotes. Nat Struct Mol Biol 2005, 12(5):408-416.
3. Carlson B.A., Xu X.M., Gladyshev V.N., Hatfield D.L. Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J Biol Chem 2005, 280(7):5542-5548.
4. Papp L.V., Lu J., Holmgren A., Khanna K.K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007, 9(7):775-806.
5. Bellinger F.P., Raman A.V., Reeves M.A., Berry M.J. Regulation, function of selenoproteins in human disease. Biochem J 2009, 422(1):11-22.
6. Copeland P.R., Fletcher J.E., Carlson B.A., Hatfield D.L., Driscoll D.M. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. Embo J 2000, 19(2):306-314.
7. Kryukov G.V., Castellano S., Novoselov S.V., et al. Characterization of mammalian selenoproteomes. Science 2003, 300(5624):1439-1443.
8. Bosl M.R., Takaku K., Oshima M., Nishimura S., Taketo M.M. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci U.S.A 1997, 94(11):5531-5534.
9. Weiss Sachdev S., Sunde R.A. Selenium regulation of transcript abundance and translational efficiency of glutathione peroxidase-1 and -4 in rat liver. Biochem J 2001, 357(Pt 3):851-858.
10. Bubenik J.L., Driscoll D.M. Altered RNA binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in selenocysteine insertion sequence-binding protein 2. J Biol Chem 2007, 282(48):34653-34662.
11. Squires J.E., Stoytchev I., Forry E.P., Berry M.J. SBP2 binding affinity is a major determinant in differential selenoprotein mRNA translation and sensitivity to nonsense-mediated decay. Mol Cell Biol 2007, 27(22):7848-7855.
12. Dumitrescu A.M., Liao X.H., Abdullah M.S., et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 2005, 37(11):1247-1252.
13. Di Cosmo C, McLellan N, Liao XH, et al. Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J Clin Endocrinol Metab 2009;94(10):4003-9.
14. Azevedo MF, Barra GB, Naves LA, et al. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J Clin Endocrinol Metab 2010;95(8):4066-4071.
15. Schoenmakers E, Agostini M, Mitchell C, et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest 2010;120(12):4220-4235.
16. Lescure A., Allmang C., Yamada K., Carbon P., Krol A. cDNA cloning, expression pattern and RNA binding analysis of human selenocysteine insertion sequence (SECIS) binding protein 2. Gene 2002, 291(1-2):279-285.
17. Copeland P.R. Regulation of gene expression by stop codon recoding: selenocysteine. Gene 2003, 312:17-25.
18. Papp L.V., Lu J., Striebel F., Kennedy D., Holmgren A., Khanna K.K. The redox state of SECIS binding protein 2 controls its localization and selenocysteine incorporation function. Mol Cell Biol 2006, 26(13):4895-4910.
19. Fletcher J.E., Copeland P.R., Driscoll D.M., Krol A. The selenocysteine incorporation machinery: interactions between the SECIS RNA and the SECIS-binding protein SBP2. Rna 2001, 7(10):1442-1453.
20. Dumitrescu AM, Di Cosmo C, Liao XH, Weiss RE, Refetoff S. The syndrome of inherited partial SBP2 deficiency in humans. Antioxid Redox Signal 2010;12(7):905-920.
21. Schomburg L., Dumitrescu A.M., Liao X.H., et al. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 2009, 19(3):277-281.
22. Burk R.F., Norsworthy B.K., Hill K.E., Motley A.K., Byrne D.W. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 2006, 15(4):804-810.
23. Xu X.M., Carlson B.A., Mix H., et al. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol 2007, 5(1):e4.